ASX - By Stock
|
CCZ |
Re:
Ann: Director Nominations
|
|
danielneil123
|
1 |
840 |
2 |
18/10/22 |
18/10/22 |
ASX - By Stock
|
1
|
840
|
2
|
|
ASX - By Stock
|
CCZ |
Re:
Cobalt and REE
|
|
danielneil123
|
70 |
20K |
3 |
27/09/22 |
27/09/22 |
ASX - By Stock
|
70
|
20K
|
3
|
|
ASX - By Stock
|
CCZ |
Re:
Ann: Approvals secured enabling BHA drilling to commence
|
|
danielneil123
|
5 |
2.2K |
3 |
21/09/22 |
21/09/22 |
ASX - By Stock
|
5
|
2.2K
|
3
|
|
ASX - By Stock
|
CCZ |
Re:
Ann: Quarterly Cashflow Report - June 2022
|
|
danielneil123
|
2 |
1.3K |
2 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
2
|
1.3K
|
2
|
|
ASX - By Stock
|
CCZ |
Re:
Media thread on off-take
|
|
danielneil123
|
28 |
14K |
1 |
16/06/22 |
16/06/22 |
ASX - By Stock
|
28
|
14K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
danielneil123
|
29 |
12K |
2 |
18/05/22 |
18/05/22 |
ASX - By Stock
|
29
|
12K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
danielneil123
|
29 |
12K |
1 |
16/05/22 |
16/05/22 |
ASX - By Stock
|
29
|
12K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
danielneil123
|
29 |
12K |
0 |
13/05/22 |
13/05/22 |
ASX - By Stock
|
29
|
12K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
danielneil123
|
29 |
12K |
1 |
12/05/22 |
12/05/22 |
ASX - By Stock
|
29
|
12K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
danielneil123
|
29 |
12K |
0 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
29
|
12K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
danielneil123
|
29 |
12K |
0 |
09/05/22 |
09/05/22 |
ASX - By Stock
|
29
|
12K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
danielneil123
|
29 |
12K |
2 |
08/05/22 |
08/05/22 |
ASX - By Stock
|
29
|
12K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
danielneil123
|
29 |
12K |
0 |
08/05/22 |
08/05/22 |
ASX - By Stock
|
29
|
12K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
danielneil123
|
29 |
12K |
0 |
08/05/22 |
08/05/22 |
ASX - By Stock
|
29
|
12K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
danielneil123
|
29 |
12K |
0 |
08/05/22 |
08/05/22 |
ASX - By Stock
|
29
|
12K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
danielneil123
|
29 |
12K |
1 |
08/05/22 |
08/05/22 |
ASX - By Stock
|
29
|
12K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
danielneil123
|
29 |
12K |
0 |
08/05/22 |
08/05/22 |
ASX - By Stock
|
29
|
12K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: New & significant data from AIPAC phase 2b trial in MBC
|
|
danielneil123
|
37 |
17K |
3 |
05/05/22 |
05/05/22 |
ASX - By Stock
|
37
|
17K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: New & significant data from AIPAC phase 2b trial in MBC
|
|
danielneil123
|
37 |
17K |
2 |
05/05/22 |
05/05/22 |
ASX - By Stock
|
37
|
17K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: New & significant data from AIPAC phase 2b trial in MBC
|
|
danielneil123
|
37 |
17K |
7 |
04/05/22 |
04/05/22 |
ASX - By Stock
|
37
|
17K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Ann: New & significant data from AIPAC phase 2b trial in MBC
|
|
danielneil123
|
37 |
17K |
14 |
04/05/22 |
04/05/22 |
ASX - By Stock
|
37
|
17K
|
14
|
|
ASX - By Stock
|
CCZ |
Re:
Ann: Board changes
|
|
danielneil123
|
9 |
4.2K |
2 |
01/04/22 |
01/04/22 |
ASX - By Stock
|
9
|
4.2K
|
2
|
|
ASX - By Stock
|
NEA |
Re:
Ann: Nearmap Group ACV portfolio surpasses $150 million
|
|
danielneil123
|
51 |
20K |
3 |
29/03/22 |
29/03/22 |
ASX - By Stock
|
51
|
20K
|
3
|
|
ASX - By Stock
|
CCZ |
Re:
Who is Dr Dennis Jensen?
|
|
danielneil123
|
11 |
3.9K |
1 |
03/03/22 |
03/03/22 |
ASX - By Stock
|
11
|
3.9K
|
1
|
|
ASX - By Stock
|
CCZ |
Re:
Who is Dr Dennis Jensen?
|
|
danielneil123
|
11 |
3.9K |
0 |
03/03/22 |
03/03/22 |
ASX - By Stock
|
11
|
3.9K
|
0
|
|
ASX - By Stock
|
CCZ |
Re:
Who is Dr Dennis Jensen?
|
|
danielneil123
|
11 |
3.9K |
1 |
03/03/22 |
03/03/22 |
ASX - By Stock
|
11
|
3.9K
|
1
|
|
ASX - By Stock
|
CCZ |
Re:
Who is Dr Dennis Jensen?
|
|
danielneil123
|
11 |
3.9K |
0 |
01/03/22 |
01/03/22 |
ASX - By Stock
|
11
|
3.9K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Proposed issue of securities - IMM
|
|
danielneil123
|
2 |
1.2K |
1 |
25/02/22 |
25/02/22 |
ASX - By Stock
|
2
|
1.2K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Appointment of Non-Executive Director
|
|
danielneil123
|
22 |
8.5K |
4 |
25/02/22 |
25/02/22 |
ASX - By Stock
|
22
|
8.5K
|
4
|
|
ASX - By Stock
|
CCZ |
Re:
Ann: Shallow Cobalt Mineralisation Identified at BHA Project
|
|
danielneil123
|
26 |
10K |
10 |
15/02/22 |
15/02/22 |
ASX - By Stock
|
26
|
10K
|
10
|
|
ASX - By Stock
|
CCZ |
Re:
Ann: Quarterly Cashflow Report - December 2021
|
|
danielneil123
|
2 |
1.1K |
2 |
07/02/22 |
07/02/22 |
ASX - By Stock
|
2
|
1.1K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Death of Director Grant Chamberlain
|
|
danielneil123
|
7 |
3.7K |
0 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
7
|
3.7K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Death of Director Grant Chamberlain
|
|
danielneil123
|
7 |
3.7K |
3 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
7
|
3.7K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Relatlimab versus Lag525
|
|
danielneil123
|
19 |
8.5K |
0 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
19
|
8.5K
|
0
|
|
ASX - By Stock
|
CCZ |
Re:
Ann: Quarterly Activities Report - December 2021
|
|
danielneil123
|
22 |
8.2K |
0 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
22
|
8.2K
|
0
|
|
ASX - By Stock
|
CCZ |
Re:
Ann: Quarterly Activities Report - December 2021
|
|
danielneil123
|
22 |
8.2K |
0 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
22
|
8.2K
|
0
|
|
ASX - By Stock
|
CCZ |
Re:
Ann: Operational Update and Board Changes
|
|
danielneil123
|
24 |
7.7K |
1 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
24
|
7.7K
|
1
|
|
ASX - By Stock
|
CCZ |
Re:
Ann: Operational Update and Board Changes
|
|
danielneil123
|
24 |
7.7K |
0 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
24
|
7.7K
|
0
|
|
ASX - By Stock
|
CCZ |
Re:
Ann: Operational Update and Board Changes
|
|
danielneil123
|
24 |
7.7K |
0 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
24
|
7.7K
|
0
|
|
ASX - By Stock
|
CCZ |
Re:
Lithium in play in a big way
|
|
danielneil123
|
181 |
78K |
2 |
29/12/21 |
29/12/21 |
ASX - By Stock
|
181
|
78K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
danielneil123
|
2.6K |
1.0M |
1 |
25/12/21 |
25/12/21 |
ASX - By Stock
|
2.6K
|
1.0M
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Marc Voight
|
|
danielneil123
|
20 |
8.9K |
1 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
20
|
8.9K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC
|
|
danielneil123
|
108 |
43K |
1 |
15/11/21 |
15/11/21 |
ASX - By Stock
|
108
|
43K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC
|
|
danielneil123
|
108 |
43K |
0 |
15/11/21 |
15/11/21 |
ASX - By Stock
|
108
|
43K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC
|
|
danielneil123
|
108 |
43K |
2 |
15/11/21 |
15/11/21 |
ASX - By Stock
|
108
|
43K
|
2
|
|
ASX - By Stock
|
CCZ |
Re:
Ann: Operational Update on Copper and Lithium Assets
|
|
danielneil123
|
72 |
30K |
4 |
11/11/21 |
11/11/21 |
ASX - By Stock
|
72
|
30K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
News: IMM Immutep Reports Phase IIb Final AIPAC Study Results
|
|
danielneil123
|
88 |
34K |
1 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
88
|
34K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
News: IMM Immutep Reports Phase IIb Final AIPAC Study Results
|
|
danielneil123
|
88 |
34K |
1 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
88
|
34K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
News: IMM Immutep Reports Phase IIb Final AIPAC Study Results
|
|
danielneil123
|
88 |
34K |
0 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
88
|
34K
|
0
|
|
ASX - By Stock
|
CCZ |
Re:
Drilling news...
|
|
danielneil123
|
63 |
24K |
0 |
08/11/21 |
08/11/21 |
ASX - By Stock
|
63
|
24K
|
0
|
|